Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor
about
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteinsThe role of suppressors of cytokine signalling in human neoplasmsRegulation of Long Bone Growth in Vertebrates; It Is Time to Catch UpInhibition and restoration of prolactin signal transduction by suppressors of cytokine signalingSuppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistanceSuppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signalSuppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signalingSOCS2 negatively regulates growth hormone action in vitro and in vivoInsulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cellsSuppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signalingSuppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanismsGlobal analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cellsKnock your SOCS off!Eukaryotic signaling pathways targeted by Salmonella effector protein AvrA in intestinal infection in vivoDoes the insulin-like growth factor system interact with prostaglandins and proinflammatory cytokines during neurodegeneration?Suppressor of cytokine signalling-6 promotes neurite outgrowth via JAK2/STAT5-mediated signalling pathway, involving negative feedback inhibition.RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulationMyxomatous mitral valve disease in dogs: does size matter?Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation.ECR-MAPK regulation in liver early development.Suppressors of cytokine signalling: SOCS.Global gene expression patterns of grass carp following compensatory growth.Serendipitous SAD Solution for DMSO-Soaked SOCS2-ElonginC-ElonginB Crystals Using Covalently Incorporated Dimethylarsenic: Insights into Substrate Receptor Conformational Flexibility in Cullin RING Ligases.A novel atlas of gene expression in human skeletal muscle reveals molecular changes associated with agingNeuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network.Genetic contributions to type 2 diabetes: recent insights.Lack of Socs2 expression reduces lifespan in high-growth mice.Genome-wide scan for hypertension linkage to chromosome 12q23.1 - q23.3 in a Chinese family.Transcriptome profiling and genome-wide DNA binding define the differential role of fenretinide and all-trans RA in regulating the death and survival of human hepatocellular carcinoma Huh7 cells.SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.SOCS proteins in development and disease.SOCS proteins in regulation of receptor tyrosine kinase signaling.Regulation of neurotrophin receptor (Trk) signaling: suppressor of cytokine signaling 2 (SOCS2) is a new player.Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity.SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.The genomic architecture of mastitis resistance in dairy sheep.Microarray analysis of Tbx5-induced genes expressed in the developing heart.
P2860
Q24293326-94B8246F-E6E7-4B83-8073-7B2DB85AB546Q24306803-3C6D1DDC-45D7-4980-872D-8B5DF63BE0E1Q24321847-999E8153-B930-4B92-935F-8F850E5C389FQ27026783-F3F417BC-D653-4393-A7D3-3456F1D54E93Q28083996-B046CC91-759B-4A37-9BE9-0D934C962487Q28142615-05744FAA-7A86-4B8C-A9FF-4F33491CD040Q28187852-E9F8B679-F191-4C26-95DC-A8B5829BF883Q28211775-18412A9A-9B2B-40F7-A065-E236A0F17D90Q28237281-623B5A14-A874-4F60-B1E7-F542CA6AC46DQ28508170-9CB5315D-CB4F-4D40-928F-B176A92A3688Q28581615-5D2019BB-CA03-4C49-9E53-53620743852AQ28585800-F2CD1A9D-B439-409D-83B0-08114945E1A9Q28586863-0376EC0E-AB12-4CF2-B4ED-4F845ADB32E5Q33553364-5E378E74-DB7E-4397-83E9-CF6913E9DE7CQ33777892-9467F6B2-7DDA-446B-B4E5-D9877E3DD342Q33779590-3C674442-8DA2-4C05-9FA4-098915495E98Q33899264-24891B63-679E-459F-84B3-F93338FA05A1Q34085697-EAE15828-9897-4DF3-8110-839C49482680Q34276776-22A37DE0-4ED9-40C2-94AC-37815549BB6AQ34387886-182F23FF-35A3-4E2D-9D18-455A3605A39FQ34636070-2E1AEF2D-7F1C-480D-A18C-FA28915B266CQ34787113-9F71D916-2088-4084-B254-F88C2DA582C5Q34798968-CA7F7364-46B8-4046-9334-75FDC1C948FBQ35088551-80C29FC4-F4A6-4053-907A-A1E727E2FF0CQ35218482-A6284B4D-EE23-40AE-A51A-EC477FDDED29Q35677393-20544B9C-C390-4FB5-97D8-A60285D13E58Q35803173-1A22ADE1-DB21-4B89-9403-35EE5077A5EBQ36649111-55570D38-969F-4244-ABA1-B29DFAD05A3DQ36748519-93EFE56F-88BA-4A0F-8A84-088B8DC7F3FEQ36979413-ED6570F2-AA6E-4155-A891-06C38B7847C8Q37073151-7B60D0C5-8C51-4F01-A7C6-E43677470BFDQ37378329-E32B2020-51D1-407A-9155-97D2B1E9697EQ37533348-4432F67A-049E-4857-8761-9317A180F655Q38124037-254170E8-7FB2-42E8-B0AB-CB4F35A10F32Q38202542-DA3DA854-E4F6-4190-9ED3-D08EB0AA4A74Q38214593-E9A0FDF0-1118-4E1F-976B-A53DD028562AQ38223318-533D4595-3C1F-44A8-9682-F09F28C8F010Q38244705-E553C7AB-E9C1-4544-8634-86BC07FCCD68Q38621713-BFFEE177-6884-4B2F-B474-EEDFF34C78CAQ40246067-060CEC0E-9942-4D5B-ADC1-AE0DA13F6C7C
P2860
Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Interaction of human suppresso ...... -like growth factor-I receptor
@ast
Interaction of human suppresso ...... -like growth factor-I receptor
@en
Interaction of human suppresso ...... -like growth factor-I receptor
@en-gb
Interaction of human suppresso ...... -like growth factor-I receptor
@nl
type
label
Interaction of human suppresso ...... -like growth factor-I receptor
@ast
Interaction of human suppresso ...... -like growth factor-I receptor
@en
Interaction of human suppresso ...... -like growth factor-I receptor
@en-gb
Interaction of human suppresso ...... -like growth factor-I receptor
@nl
prefLabel
Interaction of human suppresso ...... -like growth factor-I receptor
@ast
Interaction of human suppresso ...... -like growth factor-I receptor
@en
Interaction of human suppresso ...... -like growth factor-I receptor
@en-gb
Interaction of human suppresso ...... -like growth factor-I receptor
@nl
P2093
P2860
P921
P356
P1476
Interaction of human suppresso ...... -like growth factor-I receptor
@en
P2093
R W Furlanetto
S L Spence
P2860
P304
P356
10.1074/JBC.273.37.24095
P407
P577
1998-09-11T00:00:00Z